Patients prescribed ramipril, a medication for high blood pressure, have been warned to verify their prescriptions following a packaging error by Crescent Pharma Limited. Affected individuals may have received 10mg capsules mistakenly packaged as 2.5mg. The Medicines and Healthcare products Regulatory Agency (MHRA) has identified batch number GR155023 as the source of the error, urging users to check their medication's strength against the packaging. Symptoms of potential overdose include feeling lightheaded, fainting, or changes in kidney function, which can be serious for vulnerable patients. Those with the affected batch are advised not to take the medication and to consult their pharmacy. The MHRA has also issued instructions for healthcare professionals to halt distribution of the impacted batch and return remaining stock. This recall follows a similar incident in April involving a different batch of ramipril, highlighting ongoing concerns regarding packaging accuracy.